Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: J Neurochem. 2023 Jul 31;167(1):52–75. doi: 10.1111/jnc.15908

Table 1.

Proportion of astrocytes (ACSA-2-PE+ cells), endothelia (Pecam1-APC+ cells), and negative (ACSA-2-PE/ Pecam1-APC) cells as determined by FACS. Cultured cells were dissociated and labeled with anti-ACSA-2 antibodies coupled to the fluorophore PE and with anti-Pecam1 antibodies coupled to APC and subjected to FACS (see methods section for details). Cells were collected from a gate that excluded debris and aggregates. 20,000 events were collected per experiment, and the percentage of cells was calculated as follows: astrocytes all PE+ cells, endothelia all APC+ cells, and negative cells (negative cells = total cells - PE+ - APC+). The mean and standard deviation of five experiments (six samples per experiment) are shown.

A (Mean) A (STDEV) E (Mean) E (STDEV) Neg (Mean) Neg (STDEV)
A 94.47 4.4 0.01 0.0 5.51 4.4
EA 42.03 12.2 54.40 11.3 3.56 1.7
AN 71.94 11.1 0.00 0.0 28.06 11.1
EAN 20.79 8.6 41.89 5.7 37.32 6.2
E 0.01 0.0 97.45 1.4 2.54 1.4
N 0.57 0.2 0.13 0.1 99.30 0.3